131 related articles for article (PubMed ID: 37819312)
1. Biokinetic model analysis with DTPA administration for a case of accidental inhalation of actinides in Japan.
Tani K; Ishigure N; Kim E; Tominaga T; Tatsuzaki H; Akashi M; Kurihara O
Radiat Prot Dosimetry; 2023 Oct; 199(15-16):2025-2029. PubMed ID: 37819312
[TBL] [Abstract][Full Text] [Related]
2. Treatment of human contamination with plutonium and americium: would orally administered Ca- or Zn-DTPA be effective?
Taylor DM; Hodgson SA; Stradling N
Radiat Prot Dosimetry; 2007; 127(1-4):469-71. PubMed ID: 17556346
[TBL] [Abstract][Full Text] [Related]
3. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
Breustedt B; Blanchardon E; Bérard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
[TBL] [Abstract][Full Text] [Related]
4. AN ACCIDENT OF INTERNAL CONTAMINATION WITH PLUTONIUM AND AMERICIUM AT A NUCLEAR FACILITY IN JAPAN: A PRELIMINARY REPORT AND THE POSSIBILITY OF DTPA ADMINISTRATION ADDING TO THE DIAGNOSIS.
Tatsuzaki H; Tominaga T; Kim E; Watanabe S; Tsutsumi Y; Sagara M; Takada C; Momose T; Kurihara O; Akashi M
Radiat Prot Dosimetry; 2018 Dec; 182(1):98-103. PubMed ID: 30165696
[TBL] [Abstract][Full Text] [Related]
5. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
[TBL] [Abstract][Full Text] [Related]
6. An analysis of a puncture wound case with medical intervention.
Bailey BR; Eckerman KF; Townsend LW
Radiat Prot Dosimetry; 2003; 105(1-4):509-12. PubMed ID: 14527019
[TBL] [Abstract][Full Text] [Related]
7. The efficacies of pure LICAM(C) and DTPA for enhancing the elimination of plutonium-238 and americium-241 from rats after their inhalation as nitrate.
Stradling GN; Stather JW; Gray SA; Moody JC; Ellender M; Hodgson A
Exp Pathol; 1989; 37(1-4):83-8. PubMed ID: 2637176
[TBL] [Abstract][Full Text] [Related]
8. Plutonium-DTPA Model Application with USTUR Case 0269.
Konzen K; Brey R; Miller S
Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of orally administered amphipathic polyaminocarboxylic acid chelators for the removal of plutonium and americium: comparison with injected Zn-DTPA in the rat.
Miller SC; Liu G; Bruenger FW; Lloyd RD
Radiat Prot Dosimetry; 2006; 118(4):412-20. PubMed ID: 16332916
[TBL] [Abstract][Full Text] [Related]
10. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
James AC; Sasser LB; Stuit DB; Glover SE; Carbaugh EH
Radiat Prot Dosimetry; 2007; 127(1-4):449-55. PubMed ID: 18227077
[TBL] [Abstract][Full Text] [Related]
11. Chelation Modeling of a Plutonium-238 Inhalation Incident Treated with Delayed DTPA.
Dumit S; Miller G; Grémy O; Poudel D; Bertelli L; Klumpp JA
Radiat Res; 2023 Dec; 200(6):577-586. PubMed ID: 37956868
[TBL] [Abstract][Full Text] [Related]
12. Modelling DTPA therapy following Am contamination in rats.
Kastl M; Grémy O; Lamart S; Giussani A; Li WB; Hoeschen C
Radiat Environ Biophys; 2023 Nov; 62(4):483-495. PubMed ID: 37831188
[TBL] [Abstract][Full Text] [Related]
13. Chelation Model Validation: Modeling of a Plutonium-238 Inhalation Incident Treated with DTPA at Los Alamos National Laboratory.
Dumit S; Miller G; Poudel D; Bertelli L; Klumpp J
Health Phys; 2023 Feb; 124(2):113-124. PubMed ID: 36625835
[TBL] [Abstract][Full Text] [Related]
14. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
Dumit S; Miller G; Klumpp JA; Poudel D; Bertelli L; Waters TL
Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
[TBL] [Abstract][Full Text] [Related]
15. Influence of DTPA Treatment on Internal Dose Estimates.
Davesne E; Blanchardon E; Peleau B; Correze P; Bohand S; Franck D
Health Phys; 2016 Jun; 110(6):551-7. PubMed ID: 27115221
[TBL] [Abstract][Full Text] [Related]
16. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
17. Improved Modeling of Plutonium-DTPA Decorporation.
Dumit S; Avtandilashvili M; Strom DJ; McComish SL; Tabatadze G; Tolmachev SY
Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
[TBL] [Abstract][Full Text] [Related]
18. Decorporation of systemically distributed americium by a novel orally administered diethylenetriaminepentaacetic acid (DTPA) formulation in beagle dogs.
Wilson JP; Cobb RR; Dungan NW; Matthews LL; Eppler B; Aiello KV; Curtis S; Boger T; Guilmette RA; Weber W; Doyle-Eisele M; Talton JD
Health Phys; 2015 Mar; 108(3):308-18. PubMed ID: 25627942
[TBL] [Abstract][Full Text] [Related]
19. Validation of a system of models for plutonium decorporation therapy.
Dumit S; Avtandilashvili M; McComish SL; Strom DJ; Tabatadze G; Tolmachev SY
Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
[TBL] [Abstract][Full Text] [Related]
20. Calcium and zinc DTPA administration for internal contamination with plutonium-238 and americium-241.
Kazzi ZN; Heyl A; Ruprecht J
Curr Pharm Biotechnol; 2012 Aug; 13(10):1957-63. PubMed ID: 22352730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
